2018
DOI: 10.1111/resp.13373
|View full text |Cite
|
Sign up to set email alerts
|

Increasing diversity within the Global Lung Function Initiative

Abstract: https://onlinelibrary.wiley.com/doi/10.1111/resp.13330

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…At the transition between pediatric to adulthood (classically 18 years of age), using both pediatric and adult reference equations on the same patient could yield results varying by −14% to 38%, making their interpretation and subsequent decision-making difficult [62]. Age can further compound with race and ethnicity-among older patients from less adequately represented subgroups, e.g., older Asian patients, GLI equations were found to be less accurate than in other subgroups [63][64][65]. Therefore, determinations based on a single, nonadaptive threshold may negatively affect a broad array of clinical decisions-ranging from the prescription of medications [66] to the timely recognition of occupational lung disease [67], disease workup, and management [68].…”
Section: Plos Digital Healthmentioning
confidence: 99%
“…At the transition between pediatric to adulthood (classically 18 years of age), using both pediatric and adult reference equations on the same patient could yield results varying by −14% to 38%, making their interpretation and subsequent decision-making difficult [62]. Age can further compound with race and ethnicity-among older patients from less adequately represented subgroups, e.g., older Asian patients, GLI equations were found to be less accurate than in other subgroups [63][64][65]. Therefore, determinations based on a single, nonadaptive threshold may negatively affect a broad array of clinical decisions-ranging from the prescription of medications [66] to the timely recognition of occupational lung disease [67], disease workup, and management [68].…”
Section: Plos Digital Healthmentioning
confidence: 99%